News
Cathie Wood's recent buying activity suggests she sees national security technology as an emerging theme -- one that sits alongside more obvious artificial intelligence (AI) applications.
J.P. Morgan analyst Rachel Vatnsdal maintained a Sell rating on Twist Bioscience today and set a price target of $25.00. The company’s shares closed yesterday at $30.21. Take advantage of TipRanks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback